Guangying Zhu

Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non–Small-Cell Lung Cancer: KCSG-LU05-04

Jin Seok Ahn, Yong Chan Ahn, Joo-Hang Kim et al. · Journal of Clinical Oncology · 2015 · 258 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Long-Term Clinical Outcome of Intensity-Modulated Radiotherapy for Inoperable Non-Small Cell Lung Cancer: The MD Anderson Experience

Zhi-Qin Jiang, Kunyu Yang, Ritsuko Komaki et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 146 citations

Medicine, Oncology, Radiation Oncology +10

Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy

Anhui Shi, Guangying Zhu, Hao Wu et al. · Radiation Oncology · 2010 · 103 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.

Yin Li, Hao Wu, Jian Gong et al. · PubMed · 2012 · 57 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial

Ligang Xing, Gang Wu, Lühua Wang et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 54 citations

Medicine, Oncology, Radiation Oncology +13